NCT07318389 2026-02-27ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal CancerM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Not yet recruiting100 enrolled
NCT06067776 2023-10-05Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell CancerUniversity of California, DavisPhase 1 Not yet recruiting36 enrolled